RV2623 Dormancy Regulon Activators

The listed compounds are a mix of antibiotics, experimental drugs, and environmental conditions known to influence the dormancy state of M. tuberculosis. Traditional antibiotics like Isoniazid and Rifampin are less effective against dormant TB bacilli. Pyrazinamide, however, is more active under acidic conditions that are associated with the dormant state. Metronidazole's efficacy is tied to anaerobic conditions, which are similar to the hypoxic environment that induces dormancy in M. tuberculosis. Bedaquiline and Nitazoxanide represent newer approaches to targeting M. tuberculosis, affecting dormant cells by different mechanisms.

Vitamin D, through its role in modulating the immune response, might indirectly affect the persistence of dormant M. tuberculosis. Environmental factors like hypoxia and nutrient starvation are natural triggers for the activation of the dormancy regulon, including RV2623. Thioridazine and Clofazimine, although not standard anti-TB drugs, have shown some efficacy against M. tuberculosis, including dormant forms. Understanding and targeting the dormancy regulon, especially RV2623, is critical for developing effective strategies against latent TB infection.